Clinical trial
Leflunomide in Rheumatoid Arthritis
NCT00280644 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00280644 |
|---|---|
| Title | Leflunomide in Rheumatoid Arthritis |
| Official title | Efficacy of Leflunomide on Joint Inflammation and Destruction of Joint Integrity in Active Rheumatoid Arthritis (RA) Patients |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Arthritis, Rheumatoid |
| Intervention type | Drug |
| Interventions | Leflunomide |
| Enrollment | 60 |
| Start date | Apr 1, 2004 |
| First posted | Jan 23, 2006 |
| Last update posted | Jan 11, 2011 |
| Countries | Turkey (Türkiye) |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: